The Dermatology Digest

FEBRUARY 25, 2025

Deucravacitinib (Sotyktu, Bristol Myers Squibb) showed consistent safety and efficacy in patients with in moderate-to-severe plaque psoriasis for up to five years, new research shows. Moreover, the safety profile of deucravacitinib remained consistent through five years with no new safety signals identified.

Safety 36

Safety Clinic Sustainability Dermatology 36

AAAMS

JANUARY 3, 2025

Learn to assess patients unique features and customize treatments for natural-looking results. The Role of Hands-On Training in Patient Safety In aesthetic medicine, patient safety is paramount. The Role of Hands-On Training in Patient Safety In aesthetic medicine, patient safety is paramount.

Training 52

Training Safety Tools Injections 52

Dermatology Times

JUNE 10, 2024

Amy Paller, MD, reviews the various types of therapeutics available and coming soon for pediatric atopic dermatitis and how she decides what treatment approach is best for each patient.

Safety 73

Safety Treatments Dermatitis 73

The Dermatology Digest

DECEMBER 4, 2024

Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Restem’s umbilical cord outer lining stem cells (ULSCs) program for the treatment of dermatomyositis (DM) and polymyositis (PM). The estimated incidence of PM/DM is approximately 5 to 22 cases per 100,000 individuals. PHOTO CREDIT: DermNet The post U.S.

Treatments 36

Treatments Office Therapy Clinic 36

AAAMS

DECEMBER 16, 2024

Patients today seek treatments that offer impressive results with minimal downtime, making these procedures a must-know for practitioners aiming to stay ahead of the curve. Why Non-Surgical Treatments Are on the Rise Non-surgical cosmetic procedures are transforming the landscape of aesthetic medicine.

Chemical Peels 52

Chemical Peels Microneedling Social Media Surgery 52

AAAMS

NOVEMBER 13, 2024

These treatments are a natural fit for dental practices that focus on facial aesthetics, as they can complement smile makeovers, helping patients achieve a youthful, refreshed appearance that extends beyond their teeth. Botox®) and dermal fillers, as part of their cosmetic dentistry offerings.

Injections 52

Injections Training Facials Surgery 52

Dermatology Times

APRIL 12, 2024

She also addresses potential drug interactions, focusing on the safety of dupilumab in systemic treatment. Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and oral contraceptives.

Dermatitis 85

Dermatitis Treatments Safety Management 85

The Dermatology Digest

SEPTEMBER 27, 2024

Epicutis is launching its Arctigenin Brightening Treatment in October 2024, and the Dermatology Digest got an exclusive sneak peek of the serum. Arctigenin Brightening Treatment is EWG Verified , meaning that the product meets EWG’s strictest standards for health and safety. in an interview with TDD.

Vitamin C 74

Vitamin C Treatments Extractions Safety 74

The Dermatology Digest

DECEMBER 18, 2024

The clinical results demonstrated that STEQEYMA and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of safety and efficacy. “STEQEYMA is now the latest biologic in our immunology portfolio, joining ZYMFENTRA (infliximab-dyyb). .”

Portfolios 69

Portfolios Injections Office Safety 69

Dermatology Times

NOVEMBER 5, 2024

As news of benzene contamination in benzoyl peroxide products continues to raise safety discussions, Steve Xu, MD, MSc, advocates for stricter regulations, increased research, and the consideration of safer acne treatment alternatives.

Treatments 73

Treatments Safety 73

Kim Gallo Esthetics

DECEMBER 23, 2022

A microcurrent facial is a treatment that uses low-level electrical currents to stimulate the muscles and the skin. Microcurrent facials are one of my favorite treatments to perform because they offer so many benefits for the skin! At Kim Gallo Esthetics, your comfort and safety is our top priority.

Facials 195

Facials Esthetics Skin Types Collagen 195

The Dermatology Digest

FEBRUARY 18, 2025

Food and Drug Administration (FDA) approved mirdametinib (Gomekli, SpringWorks) for the treatment of adult and pediatric patients aged two and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) that are not amenable to complete resection. Gomekli is an oral, small molecule MEK inhibitor.

Networking 64

Networking Safety Innovations Management 64

American Esthetician Organization

AUGUST 17, 2023

If you’re one of the millions of people living with the frustrating and persistent redness and bumps of rosacea, you may have already tried a multitude of treatments. However, there’s a new contender in the field of rosacea treatments that’s gaining momentum – laser therapy.

Rosacea 88

Rosacea Treatments Medical Management 88

The Dermatology Digest

MARCH 5, 2025

first pivotal Phase 3 Spongilla Treatment for Acne Research (STAR-1) trial of Xyngari, a novel, once-weekly, topical product candidate for the treatment of moderate-to-severe acne. The XYNGARI Phase 3 STAR-1 clinical study will evaluate the efficacy, safety, and tolerability of Xyngari in patients with moderate-to-severe facial acne.

Treatments 36

Treatments Rosacea Pores Office 36

Dermatology Times

MAY 13, 2024

5 experts share insights on long-term safety, efficacy, demographic variances, and more in pediatric AD.

Safety 74

Safety Treatments 74

The Dermatology Digest

MARCH 18, 2025

has completed enrollment in its Phase 3 clinical trial evaluating aminolevulinic acid hydrochloride (Ameluz) with photodynamic therapy (PDT) for the treatment of mild to moderate actinic keratoses (AKs) on the extremities, neck, and trunk. They are then followed up for approximately one year after the last PDT treatment.

Treatments 36

Treatments Dermatology Safety Therapy 36

Dermatology Times

DECEMBER 18, 2024

The new research identified notable improvements in disease severity, sweat reduction, and quality of life for patients treated with sofpironium.

Safety 64

Safety Treatments 64

The Dermatology Digest

DECEMBER 11, 2024

Despite disappointing efficacy, ANB032 was well tolerated with no safety signals observed, the Company reported. The ARISE-AD study evaluated the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of ANB032 monotherapy in patients with moderate-to-severe AD.

Safety 36

Safety Dermatitis Therapy Dermatology 36

Alison Bladh

JANUARY 16, 2025

Safety and Precautions While saw palmetto is generally safe, there are a few important considerations to keep in mind: Potential Side Effects Mild digestive issues such as nausea, diarrhoea, or constipation may occur. To get the most benefit, choose a product that lists Serenoa repens extract as the active ingredient. link] Suter, A.

Extractions 98

Extractions Management Consultation Consultations 98

The Dermatology Digest

APRIL 7, 2024

A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Nonsteroidal treatment options for AD have rapidly expanded in recent years with the development of phosphodiesterase-4 inhibitors, biologics, and Janus kinase (JAK) inhibitors.

Treatments 77

Treatments Dermatitis Therapy Medical 77

Dermatology Times

SEPTEMBER 12, 2023

Researchers compared the efficacy of the 2 modalities and found that they were equal in safety, efficacy, and tolerability.

Safety 83

Safety Treatments 83

Dermatology Times

MARCH 28, 2025

Lisa Swanson, MD, FAAD, discusses how current treatment options for this age group fall short in terms of disease control, safety, and ease of use, while highlighting emerging options that promise better efficacy, fewer side effects, and greater convenience.

Safety 36

Safety Treatments 36

Dermatology Times

JANUARY 27, 2025

A panelist discusses how laser treatments demonstrate a strong safety profile and proven efficacy for patients with acne, with clinical studies showing significant reduction in both inflammatory and noninflammatory lesions.

Safety 36

Safety Treatments Clinic 36

Dermatology Times

NOVEMBER 25, 2024

The JAK inhibitor was significantly superior in all safety and efficacy endpoints, when compared to other AA treatment options.

Treatments 57

Treatments Safety 57

Dermatology Times

DECEMBER 12, 2024

Karan Lal, DO, MS, FAAD, discusses how to balance safety and efficacy considerations while promoting treatment adherence in young vitiligo patients, focusing on the unique challenges and monitoring requirements for this vulnerable population.

Safety 36

Safety Treatments 36

Lipgloss and Aftershave

FEBRUARY 20, 2025

While the exact cause remains unknown, her case highlights a crucial truth: IV therapy isnt just a beauty treatmentits a medical procedure that requires precision, safety, and expertise. Quality & Safety Standards Choose PCAB-accredited pharmacies for top-quality compounding. Bottom line? Do it right, or dont do it at all.

Med Spa 52

Med Spa Therapy Legal Safety 52

Dermatology Times

JANUARY 9, 2024

Experts in dermatology highlight the crucial role of setting treatment response expectations and stress the need for discussions on managing mild plaque psoriasis, highlighting the utilization of systemic therapies in this context.

Safety 77

Safety Education Therapy Management 77

Dermatology Times

AUGUST 8, 2024

Key opinion leaders examine safety concerns and adverse event trends in psoriasis treatments, discussing how these factors influence decisions to discontinue therapy and transition patients to alternative interventions.

Safety 36

Safety Treatments Therapy 36

Dermatology Times

JANUARY 8, 2024

Systemic corticosteroids are often used as primary therapy for PG, but alternatives should be considered for their favorable safety profile.

Clinic 78

Clinic Management Safety Treatments 78

The Dermatology Digest

MARCH 3, 2025

” A double-blinded, randomized, placebo-controlled trial evaluated the safety and efficacy of BioRewind in 104 patients over 12-weeks. We are confident this innovation will redefine how we think about skin health.” BioRewind is designed to be incorporated into an individual’s daily routine.

Medical Grade Skincare 74

Medical Grade Skincare Social Media Branding Skin Health 74

The Dermatology Digest

JANUARY 8, 2025

Of the 63 medical spas reviewed, 73% of treatments involving injections were performed by non-physicians. Without a physician on-site and immediately available, patient safety is compromised, as a physician with more in-depth, specialty-specific training would not be present to step in and assist if a complication occurs.

Medical 36

Medical Social Media Safety Training 36

Dermatology Times

AUGUST 10, 2023

The treatments also led to a decrease in the density of immunohistochemistry of sweat glands.

Safety 68

Safety Treatments 68

Natural Beauty Med Spa

JANUARY 4, 2025

When you think of carbon dioxide, beauty treatments might be among the last things that come to mind. But did you know that CO2 can actually provide amazing results as part of a skincare treatment? Lets talk about why you can be confident in the safety of this treatment. Do CO2Lift Treatments Have Side Effects?

Med Spa 52

Med Spa Treatments Chemical Peels Skin Types 52

Lipgloss and Aftershave

OCTOBER 30, 2024

Devices like Dio-Ice and Luxelight offer multiple wavelengths, and modalities in one platform, allowing for effective treatments on various skin types and hair densities. This versatility makes our devices suitable for a wide range of skin tones, from lighter to darker Fitzpatrick types, while maintaining comfort and safety.

Hair Removal 52

Hair Removal Skin Types Technology Safety 52

Beauty Launchpad

MARCH 13, 2025

Explore the best laser treatments for people of color to ensure safety and satisfaction.

Treatments 52

Treatments Safety Education 52

AAAMS

JANUARY 21, 2025

Why AAAM Certification is Essential for Your Medspa Starting a med spa involves more than setting up a luxurious facilityit requires a solid foundation of expertise in aesthetic procedures to provide safe, effective treatments.

Med Spa 52

Med Spa Chemical Peels Training Legal 52

Southeastern Esthetics Institute

AUGUST 23, 2016

Estheticians must obtain written permission and treatment plans through the physician overseeing the practice, with monitoring by the physician of all notations within patient charts, products and modalities used, and any other thought process made throughout the duration of treatment.

Esthetician 195

Esthetician Esthetics Document Office 195